Table 1.

Recent clinical data on benign-malignant breast lesion differentiation by elasticity imaging.

No.	Method	Number of analyzed lesions	Sensitivity	Specificity	Citation
1	USE*	52 malignant	86.5%	89.8%	Itoh A, et al. 2006 [47]
		59 benign
2	USE	135 total	100.0%	95.0%	Zhang XF, et al. 2006 [48]
3	USE	49 malignant	91.8%	91.5%	Thomas A, et al. 2006 [49]
		59 benign
4	MRE*	38 malignant	95.0%	80.0%	Sinkus R, et al. 2006 [50]
		30 benign
5	USE	88 total	96.0%	61.0%	Renger DM, et al. 2006 [51]
6	USE	43 malignant	100.0%	96.0%	Barr RG, 2007 [52]
		150 benign
7	USE	115 total	90.0%	–	Garra BS, et al. 2006 [53]
8	USE	50 malignant	99.3%	25.7%	Burnside ES, et al. 2007 [54]
		48 benign
9	USE	237 malignant	97.5%	48.0%	Svensson WE, et al. 2007 [55]
		584 benign
10	TI*	34 malignant	94.4%	–	Kaufman CS, et al. 2006 [57]
		76 benign
11	TI	33 malignant	89.4%	88.9%	Egorov V, et al. 2008 [60]
		154 benign
12	SSI*	4 malignant	100.0%	100.0%	Tanter M, et al. 2008 [75]
		11 benign

USE*—Ultrasound Elastography, MRE*—Magnetic Resonance Elastography, TI*—Tactile Imaging, SSI*—Supersonic Shear Imaging.